Attia and Mehta on modern radiation oncology and low-dose radiation for chronic inflammation
Why radiation therapy has changed dramatically, and why some clinicians believe low-dose radiation deserves more attention for chronic inflammation
Dr. Sanjay Mehta with Dr. Peter Attia
Episode aired Apr 7, 2025·Page synthesised Jun 8, 2026·Last reviewed Jun 9, 2026
What this episode covers
- Modern radiation therapy uses highly focused, computer-guided delivery to treat solid tumors like prostate and breast cancer with surgical-grade precision and limited side effects.
- Beyond oncology, low-dose radiation has been used for decades in Europe to treat chronic inflammatory conditions such as osteoarthritis (OA), plantar fasciitis, and tendonitis.
- The cancer and low-dose-inflammatory applications use very different doses and mechanisms; both may be underused in their respective clinical contexts.
- Note: the guest speaker leads a commercial radiation oncology practice, which is worth knowing when evaluating treatment-promotion framing.
Why it matters
Modern radiation therapy has become dramatically more precise and remains a cornerstone of cancer treatment. Some clinicians also argue that low-dose radiation deserves more attention for selected chronic inflammatory conditions such as osteoarthritis and tendonitis, although this application remains far less established and varies significantly between countries.
What stands out
- Low-dose radiation has been used for decades in parts of Europe, particularly Germany, for osteoarthritis, plantar fasciitis, and tendon disorders, while remaining largely absent from US, UK, Canadian, and Australian guidelines (German and Central European clinical tradition + comparative international guidelines)
- Modern precision radiation may achieve outcomes comparable to surgery for selected patients and cancer types (such as some localized prostate cancers), with substantially lower side-effect burden (mainstream radiation oncology literature)
- Cancer-dose radiation and low-dose-inflammatory radiation use fundamentally different mechanisms and risk profiles; conflating them distorts both treatment decisions and patient anxiety (mechanistic and dosing literature)
Best-supported action
The single highest-leverage move from this episode, anchored in the strongest evidence the speaker presents.
Before agreeing to or declining any radiation-based therapy, ask your clinician specifically what dose, what mechanism (ionizing or non-ionizing), and what alternative options exist.
Where to start
Small low-friction starters covering the main moves from this episode.
- Before agreeing to or declining any radiation-based therapy, ask your clinician what dose, what mechanism (ionizing or non-ionizing), and what alternative options exist for your specific case
- If you have a cancer diagnosis that may involve radiation, ask whether a referral to a radiation oncologist at an academic center would change the treatment options available to you
- For chronic inflammatory conditions like osteoarthritis or plantar fasciitis, ask whether low-dose radiation therapy is available in your region — it is more common in Europe than in the US
Other supported actions
Further actions discussed in this episode, ordered from strongest to weakest evidence. This is one expert's view, the full topic compares and ranks across experts.
- Consider asking what specific radiation technology your clinician would recommend if surgery is being considered for a localized cancer; modern precision radiation may be a comparable option worth weighing.Strong evidence
- If standard therapies have failed for chronic arthritis, plantar fasciitis, or tendonitis, ask your clinician whether low-dose radiation is discussed anywhere in the evidence base for your specific condition and whether specialist consultation would be reasonable.Moderate evidence
- Consider asking your radiologist or referring clinician what specific imaging type (MRI versus CT) gives you the diagnostic information needed with the lowest cumulative radiation exposure.Strong evidence
Full context, impact ratings, and timing — available in related topics
Questions to take to your doctor
- Given my specific localized cancer, what are the comparative cure rates and side-effect profiles of modern precision radiation versus surgery for my case?
- Given my chronic arthritis (or plantar fasciitis or tendonitis) that has not responded to standard treatments, would low-dose radiation be a reasonable next step, and is it available locally?
- Given that you are recommending radiation, can you describe the specific dose, modality, and any commercial considerations that might affect the recommendation?
Full doctor prep with ranked questions available in the full topic page
Context
Radiation oncologist with 25+ years experience and President of Century Cancer Centers in Houston (a commercial radiation oncology practice). Tends to advocate for the broader application of both modern precision oncologic radiation and the European low-dose-radiation tradition for chronic inflammatory conditions. Strongest on radiation modality details and dose-specific risk-benefit framing; the commercial-practice context is worth knowing when evaluating the strength of any treatment-promotion framing he makes.
This does not prove that radiation is the best option for every localized cancer; surgery and other treatments remain appropriate for many cases.
This does not prove that low-dose radiation for chronic inflammation works for every patient. European clinical experience is extensive, but high-quality randomized evidence remains limited compared with many standard orthopedic and rheumatologic treatments.
This does not prove that the speaker's commercial interest invalidates his clinical points, only that those points should be cross-checked with independent academic sources for high-stakes decisions.
This does not mean you should change or stop any current medical treatment on your own.
Where people go wrong
- Conflating cancer-dose radiation risk with low-dose-inflammatory radiation risk when evaluating treatment options.May lead to unnecessary anxiety about therapies that operate at very different dose levels, or to inappropriate dismissal of valid options. Cancer doses are very different from arthritis doses.
- Assuming all radiation oncology recommendations are equally objective when the recommending specialist has a commercial stake in the procedure.Strong commercial alignment does not invalidate recommendations, but it is worth knowing. For high-stakes decisions, an independent academic radiation oncology consultation may help.
What to expect over time
- Initial discussionBring specific questions about modality, dose, alternative options, and side-effect profile. Ask whether the recommending clinician has a commercial stake in the procedure.
- Treatment course (varies by application)Cancer radiation: typically several weeks of daily sessions. Low-dose inflammatory radiation: usually a handful of brief sessions over weeks. Expect dose-specific side-effect profiles.
- Long-term follow-upFor cancer treatment: regular follow-up for recurrence monitoring and long-term side effects (which may emerge years later). For low-dose-inflammatory treatment: response assessment usually within 6-12 weeks; repeat courses possible if needed.